Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Noble

Showing results (641-650 of 738) with videos related to

Pageof 74
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|March 12, 2014
Rates of adult acute inpatients documented as at risk of refeeding syndrome by dietitiansEmma L Owers, Anneli I Reeves, Susan Y Ko, et al.
Elife|February 2, 2026
Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4BOzkan Aydemir, Jeffrey A Bailey, Daniel Agardh, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2011
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitorsTimothy C Gahman, Mark R Herbert, Henk Lang, et al.
Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.
Nucleosides & Nucleotides|March 6, 1999
The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamideR Storer, C J Ashton, A D Baxter, et al.
Nucleic Acids Research|January 12, 2013
Physico-chemical foundations underpinning microarray and next-generation sequencing experimentsAndrew Harrison, Hans Binder, Arnaud Buhot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2014
Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacyNeil Gupta, Susan N Hocevar, Heather A Moulton-Meissner, et al.
Annals of the Rheumatic Diseases|April 10, 2017
Increased risk of rheumatoid arthritis among mothers with children who carry <i>DRB1</i> risk-associated allelesGiovanna Ibeth Cruz, Xiaorong Shao, Hong Quach, et al.
Journal of the American Chemical Society|October 27, 2023
Colossal C<sub>130</sub> Fullertubes: Soluble [5,5] C<sub>130</sub>-D<sub>5h</sub>(1) Pristine Molecules with 70 Nanotube Carbons and Two 30-Atom Hemifullerene End-capsEmmanuel Bourret, Xiaoyang Liu, Cora A Noble, et al.
Haematologica|April 8, 2017
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphomaRichard A Noble, Natalie Bell, Helen Blair, et al.
Pageof 74

Showing results (641-650 of 738) with videos related to

Sort By:
Pageof 74
Clinical Nutrition (Edinburgh, Scotland)|March 12, 2014
Rates of adult acute inpatients documented as at risk of refeeding syndrome by dietitiansEmma L Owers, Anneli I Reeves, Susan Y Ko, et al.
Elife|February 2, 2026
Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4BOzkan Aydemir, Jeffrey A Bailey, Daniel Agardh, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2011
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitorsTimothy C Gahman, Mark R Herbert, Henk Lang, et al.
Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.
Nucleosides & Nucleotides|March 6, 1999
The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamideR Storer, C J Ashton, A D Baxter, et al.
Nucleic Acids Research|January 12, 2013
Physico-chemical foundations underpinning microarray and next-generation sequencing experimentsAndrew Harrison, Hans Binder, Arnaud Buhot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2014
Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacyNeil Gupta, Susan N Hocevar, Heather A Moulton-Meissner, et al.
Annals of the Rheumatic Diseases|April 10, 2017
Increased risk of rheumatoid arthritis among mothers with children who carry <i>DRB1</i> risk-associated allelesGiovanna Ibeth Cruz, Xiaorong Shao, Hong Quach, et al.
Journal of the American Chemical Society|October 27, 2023
Colossal C<sub>130</sub> Fullertubes: Soluble [5,5] C<sub>130</sub>-D<sub>5h</sub>(1) Pristine Molecules with 70 Nanotube Carbons and Two 30-Atom Hemifullerene End-capsEmmanuel Bourret, Xiaoyang Liu, Cora A Noble, et al.
Haematologica|April 8, 2017
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphomaRichard A Noble, Natalie Bell, Helen Blair, et al.
Pageof 74